Get notified when NUS files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsNu Skin refinances credit facility with $175M term loan and $75M revolver
Filed March 27, 2026 · Period ending March 27, 2026 · ~1 min read
Key Changes
-
high
Company must maintain leverage ratio below 2.25x and interest coverage above 3.00x, providing guardrails on debt levels and servicing capacity.
Item 1.01 — Entry into a Material Definitive Agreement verify on EDGAR → -
medium
New five-year facility comprises $175M term loan (drawn in full at closing) and $75M revolver, replacing prior June 2022 credit agreement.
Item 1.01 — Entry into a Material Definitive Agreement verify on EDGAR → -
medium
Term loan requires 10% annual amortization ($17.5M/year in quarterly installments), with remaining balance due at maturity in 2031.
Item 1.01 — Entry into a Material Definitive Agreement verify on EDGAR →
2 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (PXED 10-Q) is open in full — no account needed.
Partner
Trade NUS commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Source-verified from EDGAR · Narrative written by AI · Jun 21, 2026 · How we verify